Verrica Pharmaceuticals Inc. Operating Lease, Liability, Current
Verrica Pharmaceuticals Inc. (VRCA) had Operating Lease, Liability, Current of $355.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Current $355.00K.
- 2026-03-31: Operating Lease, Liability, Current $348.00K.
- 2025-12-31: Operating Lease, Liability, Current $341.00K.
- 2025-09-30: Operating Lease, Liability, Current $335.00K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $355.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $348.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $341.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $335.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $328.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $321.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $315.00K 10-K · filed 2026-03-11 | |
| 2024-09-30 | $315.00K 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $332.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $331.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $324.00K 10-K · filed 2025-03-11 | |
| 2023-09-30 | $316.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $309.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $302.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $297.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $291.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $283.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $250.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $245.00K 10-K · filed 2023-03-06 | $244.60K 10-K · filed 2022-03-02 |
| 2021-09-30 | $239.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $235.00K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $230.00K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $198.00K 10-K · filed 2022-03-02 | |
| 2020-09-30 | $245.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $124.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $133.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $130.00K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $127.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $124.00K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $122.00K 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |